![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: PEX2 |
Gene summary for PEX2 |
![]() |
Gene information | Species | Human | Gene symbol | PEX2 | Gene ID | 5828 |
Gene name | peroxisomal biogenesis factor 2 | |
Gene Alias | PAF1 | |
Cytomap | 8q21.13 | |
Gene Type | protein-coding | GO ID | GO:0000038 | UniProtAcc | P28328 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
5828 | PEX2 | LZE2T | Human | Esophagus | ESCC | 4.61e-03 | 2.53e-01 | 0.082 |
5828 | PEX2 | LZE4T | Human | Esophagus | ESCC | 7.23e-18 | 3.89e-01 | 0.0811 |
5828 | PEX2 | LZE5T | Human | Esophagus | ESCC | 1.29e-04 | 1.71e-01 | 0.0514 |
5828 | PEX2 | LZE7T | Human | Esophagus | ESCC | 1.88e-07 | 3.21e-01 | 0.0667 |
5828 | PEX2 | LZE8T | Human | Esophagus | ESCC | 1.55e-14 | 3.24e-01 | 0.067 |
5828 | PEX2 | LZE20T | Human | Esophagus | ESCC | 8.05e-16 | 4.67e-01 | 0.0662 |
5828 | PEX2 | LZE22T | Human | Esophagus | ESCC | 9.95e-03 | 1.71e-01 | 0.068 |
5828 | PEX2 | LZE24T | Human | Esophagus | ESCC | 8.40e-23 | 6.74e-01 | 0.0596 |
5828 | PEX2 | LZE6T | Human | Esophagus | ESCC | 2.54e-04 | 1.41e-01 | 0.0845 |
5828 | PEX2 | P1T-E | Human | Esophagus | ESCC | 7.98e-05 | 4.46e-01 | 0.0875 |
5828 | PEX2 | P2T-E | Human | Esophagus | ESCC | 6.95e-34 | 5.09e-01 | 0.1177 |
5828 | PEX2 | P4T-E | Human | Esophagus | ESCC | 2.01e-38 | 7.15e-01 | 0.1323 |
5828 | PEX2 | P5T-E | Human | Esophagus | ESCC | 5.91e-16 | 2.97e-01 | 0.1327 |
5828 | PEX2 | P8T-E | Human | Esophagus | ESCC | 9.60e-30 | 4.80e-01 | 0.0889 |
5828 | PEX2 | P9T-E | Human | Esophagus | ESCC | 2.68e-17 | 3.20e-01 | 0.1131 |
5828 | PEX2 | P10T-E | Human | Esophagus | ESCC | 8.76e-42 | 7.08e-01 | 0.116 |
5828 | PEX2 | P11T-E | Human | Esophagus | ESCC | 2.04e-14 | 5.64e-01 | 0.1426 |
5828 | PEX2 | P12T-E | Human | Esophagus | ESCC | 1.08e-40 | 7.40e-01 | 0.1122 |
5828 | PEX2 | P15T-E | Human | Esophagus | ESCC | 4.42e-21 | 4.39e-01 | 0.1149 |
5828 | PEX2 | P16T-E | Human | Esophagus | ESCC | 6.01e-40 | 7.47e-01 | 0.1153 |
Page: 1 2 3 4 5 6 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0072594 | Colorectum | AD | establishment of protein localization to organelle | 148/3918 | 422/18723 | 7.95e-12 | 1.04e-09 | 148 |
GO:0090150 | Colorectum | AD | establishment of protein localization to membrane | 100/3918 | 260/18723 | 6.01e-11 | 6.33e-09 | 100 |
GO:0006605 | Colorectum | AD | protein targeting | 105/3918 | 314/18723 | 1.39e-07 | 6.44e-06 | 105 |
GO:0017038 | Colorectum | AD | protein import | 67/3918 | 206/18723 | 6.34e-05 | 1.05e-03 | 67 |
GO:0071806 | Colorectum | AD | protein transmembrane transport | 21/3918 | 59/18723 | 6.58e-03 | 4.08e-02 | 21 |
GO:00725941 | Colorectum | SER | establishment of protein localization to organelle | 111/2897 | 422/18723 | 4.98e-09 | 4.49e-07 | 111 |
GO:00901501 | Colorectum | SER | establishment of protein localization to membrane | 68/2897 | 260/18723 | 5.55e-06 | 2.01e-04 | 68 |
GO:00066051 | Colorectum | SER | protein targeting | 76/2897 | 314/18723 | 3.19e-05 | 8.47e-04 | 76 |
GO:00170381 | Colorectum | SER | protein import | 49/2897 | 206/18723 | 1.12e-03 | 1.29e-02 | 49 |
GO:00718061 | Colorectum | SER | protein transmembrane transport | 17/2897 | 59/18723 | 6.64e-03 | 4.69e-02 | 17 |
GO:00901504 | Colorectum | FAP | establishment of protein localization to membrane | 69/2622 | 260/18723 | 6.40e-08 | 4.54e-06 | 69 |
GO:00725944 | Colorectum | FAP | establishment of protein localization to organelle | 96/2622 | 422/18723 | 6.63e-07 | 3.20e-05 | 96 |
GO:00066054 | Colorectum | FAP | protein targeting | 74/2622 | 314/18723 | 3.21e-06 | 1.17e-04 | 74 |
GO:00170384 | Colorectum | FAP | protein import | 47/2622 | 206/18723 | 4.10e-04 | 4.94e-03 | 47 |
GO:0006612 | Colorectum | FAP | protein targeting to membrane | 30/2622 | 131/18723 | 3.95e-03 | 2.75e-02 | 30 |
GO:00650021 | Colorectum | FAP | intracellular protein transmembrane transport | 14/2622 | 51/18723 | 8.70e-03 | 4.98e-02 | 14 |
GO:0072594110 | Esophagus | ESCC | establishment of protein localization to organelle | 311/8552 | 422/18723 | 3.02e-32 | 2.13e-29 | 311 |
GO:0031647111 | Esophagus | ESCC | regulation of protein stability | 223/8552 | 298/18723 | 5.76e-25 | 1.52e-22 | 223 |
GO:0006605111 | Esophagus | ESCC | protein targeting | 229/8552 | 314/18723 | 4.93e-23 | 1.01e-20 | 229 |
GO:0090150110 | Esophagus | ESCC | establishment of protein localization to membrane | 182/8552 | 260/18723 | 1.27e-15 | 8.19e-14 | 182 |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa041467 | Esophagus | ESCC | Peroxisome | 55/4205 | 82/8465 | 1.04e-03 | 3.27e-03 | 1.68e-03 | 55 |
hsa0414612 | Esophagus | ESCC | Peroxisome | 55/4205 | 82/8465 | 1.04e-03 | 3.27e-03 | 1.68e-03 | 55 |
hsa041462 | Liver | Cirrhotic | Peroxisome | 36/2530 | 82/8465 | 4.79e-03 | 1.74e-02 | 1.07e-02 | 36 |
hsa041463 | Liver | Cirrhotic | Peroxisome | 36/2530 | 82/8465 | 4.79e-03 | 1.74e-02 | 1.07e-02 | 36 |
hsa041464 | Liver | HCC | Peroxisome | 58/4020 | 82/8465 | 1.57e-05 | 1.05e-04 | 5.85e-05 | 58 |
hsa041465 | Liver | HCC | Peroxisome | 58/4020 | 82/8465 | 1.57e-05 | 1.05e-04 | 5.85e-05 | 58 |
hsa041466 | Oral cavity | OSCC | Peroxisome | 47/3704 | 82/8465 | 9.01e-03 | 2.01e-02 | 1.03e-02 | 47 |
hsa0414611 | Oral cavity | OSCC | Peroxisome | 47/3704 | 82/8465 | 9.01e-03 | 2.01e-02 | 1.03e-02 | 47 |
hsa0414621 | Oral cavity | LP | Peroxisome | 33/2418 | 82/8465 | 1.48e-02 | 4.69e-02 | 3.03e-02 | 33 |
hsa0414631 | Oral cavity | LP | Peroxisome | 33/2418 | 82/8465 | 1.48e-02 | 4.69e-02 | 3.03e-02 | 33 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
PEX2 | SNV | Missense_Mutation | rs148101729 | c.322N>C | p.Val108Leu | p.V108L | P28328 | protein_coding | tolerated(0.91) | benign(0.001) | TCGA-77-7141-01 | Lung | lung squamous cell carcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
PEX2 | SNV | Missense_Mutation | novel | c.537G>C | p.Lys179Asn | p.K179N | P28328 | protein_coding | deleterious(0.02) | benign(0.056) | TCGA-85-8352-01 | Lung | lung squamous cell carcinoma | Male | >=65 | III/IV | Unknown | Unknown | PD |
PEX2 | SNV | Missense_Mutation | novel | c.532N>C | p.Cys178Arg | p.C178R | P28328 | protein_coding | tolerated(0.17) | benign(0.038) | TCGA-85-8666-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
PEX2 | SNV | Missense_Mutation | c.314N>C | p.Trp105Ser | p.W105S | P28328 | protein_coding | tolerated(0.29) | benign(0.224) | TCGA-NC-A5HM-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
PEX2 | SNV | Missense_Mutation | novel | c.73N>A | p.Leu25Ile | p.L25I | P28328 | protein_coding | deleterious(0) | probably_damaging(0.998) | TCGA-CV-7261-01 | Oral cavity | head & neck squamous cell carcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
PEX2 | insertion | Frame_Shift_Ins | novel | c.758dupT | p.Met253IlefsTer8 | p.M253Ifs*8 | P28328 | protein_coding | TCGA-CV-7415-01 | Oral cavity | head & neck squamous cell carcinoma | Male | <65 | I/II | Unknown | Unknown | PD | ||
PEX2 | SNV | Missense_Mutation | novel | c.767N>T | p.Thr256Ile | p.T256I | P28328 | protein_coding | tolerated(0.05) | possibly_damaging(0.623) | TCGA-YL-A8HM-01 | Prostate | prostate adenocarcinoma | Male | >=65 | 9 | Hormone Therapy | casodex | PD |
PEX2 | SNV | Missense_Mutation | c.86T>C | p.Leu29Pro | p.L29P | P28328 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-CG-4306-01 | Stomach | stomach adenocarcinoma | Male | >=65 | III/IV | Unknown | Unknown | SD | |
PEX2 | SNV | Missense_Mutation | c.172N>A | p.Ala58Thr | p.A58T | P28328 | protein_coding | deleterious(0.03) | possibly_damaging(0.832) | TCGA-CG-4442-01 | Stomach | stomach adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
PEX2 | SNV | Missense_Mutation | rs752394595 | c.505N>T | p.Arg169Cys | p.R169C | P28328 | protein_coding | deleterious(0.03) | probably_damaging(1) | TCGA-CG-5721-01 | Stomach | stomach adenocarcinoma | Male | <65 | III/IV | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |